×

Exact Sciences CEO: Medicare Spending & Cologuard Test

6:45 PM ET Mon, 7 Jan 2013

Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.